Safety and Feasibility of Umbilical Cord Blood Cell Transplant Into Injured Spinal Cord

NCT01046786 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

8

Enrollment

NETWORK

Sponsor class

Conditions

Spinal Cord Injuries

Interventions

BIOLOGICAL: Umbilical Cord Blood Mononuclear Cell
DRUG: Methylprednisolone
DRUG: Lithium

Sponsor

China Spinal Cord Injury Network

Collaborators

[object Object]
[object Object]